SCHEMBL6072647

SCHEMBL6072647

CNC(=O)c1cc(Oc2ccc3c(c2)CCN3C(=O)NC2CCCCC2)ccn1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAF1 P04049 2/20 0.54
BRAF P15056 2/20 0.54
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
KDR P35968 6/20 0.50
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NFKB1 P19838 3/20 0.47
NR2C2 P49116 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
TAB1 Q15750 3/20 0.47
HRH3 Q9Y5N1 1/20 0.47
TSHR P16473 1/20 0.45
CSF1R P07333 5/20 0.45
PDGFRB P09619 1/20 0.44
KIT P10721 1/20 0.44
PDGFRA P16234 1/20 0.44
FLT3 P36888 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6071927 0.83 KDR (0.52) RAF1BRAFKDRNFKB1NR2C2
SCHEMBL6072111 0.83 KDR (0.53) RAF1BRAFKDRNFKB1NR2C2
SCHEMBL6072414 0.83 KDR (0.52) RAF1BRAFKDRNFKB1NR2C2
SCHEMBL6071883 0.82 KDR (0.51) RAF1BRAFKDRNFKB1NR2C2
SCHEMBL6072418 0.80 KDR (0.47) RAF1BRAFKDRMAPK14
SCHEMBL6072374 0.79 KDR (0.58) RAF1BRAFKDRNPC1RAB9A
SCHEMBL14793110 0.79 KDR (0.69) RAF1BRAFMEN1KMT2AKDR
SCHEMBL6072949 0.79 KDR (0.51) RAF1BRAFKDRNFKB1NR2C2
SCHEMBL6072483 0.79 KDR (0.61) RAF1BRAFMEN1KMT2AKDR
SCHEMBL14793075 0.78 KDR (0.70) RAF1BRAFMEN1KMT2AKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060241149-A1 Chemical compounds ADAMS JERRY L 2006-10-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060241149-A1 Chemical compounds CHKB, MAP3K20, MAP3K6 RAF1 205/4885BRAF 191/4885MEN1 3087/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.